XOMAP (STOCKS)
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
$25.980000
+0.080000 (+0.31%)
Prev close: $25.900000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Owen Patrick Hughes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $283.67M
- Employees
- 13
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $47.11M |
| Benefits Costs and Expenses | $31.07M |
| Costs And Expenses | $31.07M |
| Operating Expenses | $45.16M |
| Research and Development | $2.30M |
| Other Operating Expenses | $42.86M |
| Operating Income/Loss | $1.95M |
| Income/Loss From Continuing Operations After Tax | $21.64M |
| Income/Loss From Continuing Operations Before Tax | $16.03M |
| Income Tax Expense/Benefit | -$5.61M |
| Net Income/Loss | $21.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $21.64M |
| Net Income/Loss Available To Common Stockholders, Basic | $13.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $10.14M |
| Preferred Stock Dividends And Other Adjustments | $6.44M |
| Basic Earnings Per Share | $0.81 |
| Diluted Earnings Per Share | $0.75 |
| Basic Average Shares | 12,094,000 |
| Diluted Average Shares | 17,988,000 |
| Assets | $263.15M |
| Current Assets | $110.71M |
| Noncurrent Assets | $152.44M |
| Fixed Assets | $24.00K |
| Intangible Assets | $44.56M |
| Other Non-current Assets | $107.86M |
| Liabilities | $155.19M |
| Current Liabilities | $28.31M |
| Accounts Payable | $2.65M |
| Other Current Liabilities | $25.65M |
| Noncurrent Liabilities | $126.89M |
| Redeemable Noncontrolling Interest | $20.02M |
| Redeemable Noncontrolling Interest, Preferred | $20.02M |
| Equity | $87.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $87.94M |
| Temporary Equity | $20.02M |
| Temporary Equity Attributable To Parent | $20.00M |
| Liabilities And Equity | $263.15M |
| Net Cash Flow From Operating Activities | $5.47M |
| Net Cash Flow From Operating Activities, Continuing | $5.47M |
| Net Cash Flow From Investing Activities | -$4.89M |
| Net Cash Flow From Investing Activities, Continuing | -$4.89M |
| Net Cash Flow From Financing Activities | -$16.84M |
| Net Cash Flow From Financing Activities, Continuing | -$16.84M |
| Net Cash Flow | -$16.26M |
| Net Cash Flow, Continuing | -$16.26M |
| Comprehensive Income/Loss | $21.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $21.66M |
| Other Comprehensive Income/Loss | $22.00K |